Loading insider details...
Latest Form 4 (May 29, 2026): Grant/Award of 80,000 NMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 80,000 | n/a |
| May 30, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 46,455 | n/a |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 46,455 | n/a |
| Jun 14, 2024 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 20,100 | n/a |
| Sep 18, 2023 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 46,455 | n/a |
| May 4, 2021 | AMGEN INC (AMGN) | Grant/Award | 709 | n/a |
| Apr 29, 2021 | AMGEN INC (AMGN) | Tax Withholding | 128 | $32.7K |
| Mar 22, 2021 | AMGEN INC (AMGN) | Tax Withholding | 991 | $242.2K |
| Mar 5, 2021 | AMGEN INC (AMGN) | Grant/Award | 2,648 | n/a |
| May 8, 2020 | AMGEN INC (AMGN) | Grant/Award | 1,269 | n/a |